10-Q

$SYK · Stryker Corporation

October 30, 2026 · AI-analyzed SEC filing · Verify material figures against the official SEC.gov filing

Stryker Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026. The report contains the company’s unaudited condensed consolidated financial statements for the three and nine months ended September 30, 2026, along with comparative figures for the same periods in 2025. The filing covers Stryker’s two reportable segments: MedSurg and Neurotechnology, and Orthopaedics and Spine.

Within MedSurg and Neurotechnology, the filing includes results for Instruments, Endoscopy, Medical, and Neurovascular product lines. Within Orthopaedics and Spine, it includes Knees, Hips, Trauma and Extremities, OrthoTech, and Spinal Implants. The document also presents balance sheet, equity, and debt information, including details on several senior unsecured notes with maturities ranging from 2027 to 2036.

The extracted text does not include specific revenue or earnings figures, so no particular financial result or one-time event is highlighted. The filing appears to be a routine quarterly report rather than an announcement of a major transaction or unusual occurrence.

Get filings like this before the market reacts.

Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.

Start your free trial →